Tirzepatide
The most powerful FDA-approved weight loss injection — up to 25% body weight reduction. Tirzepatide is the first dual GIP/GLP-1 receptor agonist, FDA-approved for type 2 diabetes and weight management. Its dual mechanism produces superior weight loss (20-25% in trials) compared to GLP-1-only medications. Administered once weekly with powerful effects on appetite, blood sugar, and body composition.
Compare Prices🧬Key Characteristics
- Length: 39 amino acids(Based on GIP sequence.)
- Half-life: ~5 days(Allows weekly dosing.)
- Mechanism: Dual GIP/GLP-1(Two incretin pathways.)
- Primary Use: Weight loss(Enhanced efficacy vs. GLP-1 alone.)
Overview
Core Benefits
Key AdvantagesThese are educational summaries of commonly discussed effects in wellness/regenerative contexts, not guarantees.
Tirzepatide Results Timeline
ProgressionTimeline is illustrative and non-guaranteed. Outcomes vary and are commonly discussed alongside training, nutrition, sleep, and cycling practices.
How It Works
Dual GIP/GLP-1 Receptor AgonistReceptor → Metabolic Cascade → Weight & Glucose → Outcomes
GIP + GLP-1 Receptors — Dual Incretin Activation
Tirzepatide is the first approved dual agonist, targeting both GIP and GLP-1 receptors simultaneously. This dual mechanism produces synergistic effects on appetite, insulin sensitivity, and fat metabolism that exceed what either pathway achieves alone.
Dual cAMP Activation → Enhanced Insulin + Satiety
GLP-1 receptor activation drives appetite suppression and insulin secretion. GIP receptor activation enhances fat metabolism and may improve beta cell function. The dual signal produces a metabolic effect greater than the sum of its parts.
Superior Appetite Control + Metabolic Optimization
Clinical trials show 20-25% body weight reduction — the highest of any approved medication. Enhanced glucose control often achieves near-normal A1C levels. The GIP component may help preserve lean mass during weight loss.
Strong Appetite Reduction → Exceptional Weight Loss
Appetite suppression is typically stronger than with semaglutide. Weight loss is steady and significant. GI side effects (nausea) are common during titration but generally manageable. Blood sugar normalization can be dramatic.
What Makes This Peptide Different
Tirzepatide's dual GIP/GLP-1 mechanism produces 20-25% weight loss — about 5% more than semaglutide alone. The GIP component adds metabolic benefits that pure GLP-1 agonists lack. It represents the next generation beyond semaglutide. The upcoming Retatrutide adds a third receptor (glucagon) for potentially even greater effects.
Dosing Protocol
Weight Loss / DiabetesEducational reference only. Individual responses vary. Consult healthcare provider before use.
Popular Stack Protocols
1 stackCommonly paired protocols from the peptide research community. Educational reference only.
🧬 Semaglutide + Tirzepatide
Weight Loss (Sequential)Why This Dosing Protocol
Why slow titration? Same principle as semaglutide — titrating from 2.5mg up through 5, 7.5, 10, 12.5, to 15mg over weeks minimizes GI side effects.
Why weekly? Extended half-life allows once-weekly injection with consistent efficacy throughout the week.
Diagrams
Hover for preview • Click to open full size
Tirzepatide Pricing
We surface in-stock offers first and normalize by price per mg for quick comparisons.
5 mg / vial
In-stock offers10 mg / vial
In-stock offersBuy more, save more
15 mg / vial
In-stock offers20 mg / vial
In-stock offers30 mg / vial
In-stock offers60 mg / vial
In-stock offersLooking for medical guidance?
Join the waitlist for doctor-guided peptide plans. We'll notify you when telehealth consultations are available in your state.
Reconstitution calculator
Dilution math and unit conversions. Prefilled using a common vial size for this peptide.
Open calculatorEducational Videos
How to Reconstitute Peptides
Handling
Educational overview on storage, labeling, and traceability considerations for lab environments. Consult primary literature and vendor documentation for specifics.
- Freezer (-20°C): 1+ year ✓
- Refrigerator (2-8°C): 1-3 months ✓
- Room temperature: 2-3 weeks (emergency only)
- MUST refrigerate at 2-8°C
- 4-week maximum shelf life
- NEVER freeze after reconstitution
- Use bacteriostatic water for multi-dose
Storage & Handling Guide
Learn proper storage temperatures, shelf life timelines, reconstitution best practices, and travel tips for lyophilized and reconstituted peptides.
FAQ
Why is tirzepatide more effective than other weight loss medications?
Tirzepatide is a "dual agonist" — it activates both GIP and GLP-1 receptors, while other medications like semaglutide only target GLP-1. This dual action provides synergistic effects on appetite, glucose control, and fat burning, resulting in 20-25% weight loss in trials — the highest of any approved medication.
Is tirzepatide approved for both diabetes and weight loss?
Yes, tirzepatide is FDA-approved for both type 2 diabetes and chronic weight management in adults with obesity or overweight with weight-related conditions. The formulation is identical for both uses; they differ only in approved indication.
What are the side effects of tirzepatide?
Common side effects include nausea, diarrhea, decreased appetite, vomiting, and constipation. These are typically most pronounced during dose escalation and improve over time. GI effects may be more intense than with GLP-1-only medications due to the dual mechanism. Rare serious effects include pancreatitis and thyroid tumors (in animal studies).
How does tirzepatide compare to semaglutide?
Head-to-head trials show tirzepatide produces greater weight loss than semaglutide (about 5% more on average). Tirzepatide's dual GIP/GLP-1 action also tends to produce better blood sugar control. However, semaglutide has a longer safety track record. Both are effective; tirzepatide may be preferred when maximum weight loss is the priority.
What is GIP and why does adding it to GLP-1 help?
GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone like GLP-1. While GLP-1 primarily reduces appetite, GIP enhances insulin secretion and may directly affect fat tissue. Together they provide complementary mechanisms: better appetite control, improved glucose handling, and potentially enhanced fat metabolism.
What is the typical tirzepatide dosing schedule?
A common research dosage is 0.5 mg (10 units on 1ml syringe) administered 3 times per week in the AM. Protocol: 8 weeks on, 8 weeks off or until goal weight is reached. Best taken on an empty stomach.
How much weight can I expect to lose on tirzepatide?
Clinical trials showed average weight loss of 20-22% of body weight at higher doses over 72 weeks. Some participants lost over 25%. This is the highest weight loss achieved by any approved medication. Results vary based on dose, diet, exercise, and individual response.
Is tirzepatide available as a compounded medication?
Due to FDA-approved brand shortages, compounding pharmacies have produced tirzepatide. However, the FDA has updated shortage lists, which affects compounding legality. Always verify current regulations and source from reputable providers. The FDA-approved versions remain the standard.
How long does reconstituted peptide last?
Once mixed with bacteriostatic water, peptides remain stable for up to 4 weeks when refrigerated at 2-8°C (36-46°F). Unopened powder can last 1+ year in the freezer. Get our complete Storage & Travel Guide.
Is this peptide legal to purchase?
Peptides sold "for research purposes only" are legal to purchase in the US, but are not FDA-approved for human use outside of specific medical applications. Always consult a healthcare provider before use.
New to peptides?
Take our Peptide Match tool to find the best peptide for your goals. You can also read our Complete Guide to Peptides to learn the basics.
Scientific Sources
The following peer-reviewed studies and official resources provide additional scientific context for this peptide:
Disclosure: we may earn affiliate commission from qualifying purchases. Educational information only — not medical advice.